LISA COBB: Open Payments
NPI 1417485129 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,011 in 215 payments from 45 companies in 2025. Trend: 2023 $721 · 2024 $4,586 · 2025 $5,011
Food & beverage: $4,792Education: $219
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $580 |
| AstraZeneca Pharmaceuticals LP | 14 | $429 |
| Daiichi Sankyo Inc. | 17 | $407 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $329 |
| Novartis Pharmaceuticals Corporation | 13 | $327 |
| PFIZER INC. | 15 | $246 |
| Celgene Corporation | 14 | $241 |
| Incyte Corporation | 12 | $200 |
| Astellas Pharma US Inc | 6 | $186 |
| Eisai Inc. | 8 | $180 |
Products named: Enhertu, Nubeqa, RYBREVANT, REBLOZYL, TECVAYLI, Lenvima, KEYTRUDA, LONSURF.
Industry payments across SC — which companies pay providers there.
